|
BD Medical Launches Pro-safety IV Catheter To Help Health
Workers
BD Medical, a segment of BD (Becton, Dickinson and Company), a leading global
medical technology company, has launched the Venflon pro- safety IV catheter
with safety features against needlestick injury. The product is launched in the
wake of studies suggesting that over one million needlestick injuries occur
every year worldwide.
The new product, launched in India today, will extend protection against
needlestick injuries and minimise the risk due to blood exposure, especially for
the health workers. Needlestick injuries can lead to the transmission of fatal
blood borne infections including hepatitis B virus (HBV), hepatitis C virus (HCV)
and the human immunodeficiency virus (HIV). Studies have found that each year,
sharps injuries are responsible for over 65,000 new HBV infections, 16,000 new
HCV infections and 1,000 new HIV infections.
According to a study conducted at the Hinduja hospital in Mumbai, most
needlestick injuries occur during intravenous line insertion, followed by blood
collection and then surgical blade injury and recapping needles, said BD India
managing director Ram Sharma after launching the product.
It was launched in Europe two months ago and the Indian subsidiary has
brought it now in the Indian markets, considering the need of such technologies
here. The company, which also launched a product for patient care a few months
back, was looking to introduce more innovative products here, BD Medical general
manager Rajnish Rohatgi told Pharmabiz.
The BD Venflon pro-safety catheter has an advanced needle shield design to
safeguard healthcare workers from needlestick injuries. Once activated, the
needle tip is encapsulated inside the smooth-edged plastic shield, thereby
reducing the risk of healthcare workers injuring themselves with the sharp
needle tip. In fact, in a recent study conducted in clinics in Europe, over 86
per cent gave BD Venflon pro-safety catheter a more than adequate rating for
protection against needlestick injuries.
(Ref : Chronicle Pharmabiz dated May 10, 2007)
Time Technoplast To Set Up Medical Devices Unit In Baddi
The Mumbai-based Time Technoplast, a technology based company, is setting up
a new manufacturing facility of disposable medical devices at Thane near Baddi.
It is investing Rs. 35 crore and the commercial production is expected to
commence from October 2007.
Talking to Pharmabiz, Anil Jain, managing director, said, "We are already in
the manufacturing of healthcare products such as auto disable, blood collection
device and multi layer face masks. For the Baddi expansion we have already
purchased land with at a cost of Rs. three crore. We are also investing around
Rs. 30 crore for the plant and machinery. The implementation of the project is
in advanced stage and is likely to go on stream by October 2007. We have already
set up marketing network for the domestic market."
The company has engaged in the manufacturing and sale of technology based
polymer products. Recently, company has entered into the healthcare business
segment by introducing auto disable syringe under the brand name Genex. The
company has subsequently launched auto collect blood disable syringe and
protective facemask. Protective facemask is basically used in the operation
theatre, clinical care department, and quarantine areas. It is highly advanced
mask which is not only protects the user in a bacterial air borne environment,
but also protect from the blood and body ward, fumigation and cleaning areas,
laboratories and clinics.
(Ref : Chronicle Pharmabiz dated May 17, 2007).
|
